About
About Amplitude Surgical SA
Amplitude Surgical SA designs, develops, and markets products for orthopedic surgery in France and internationally. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgery system; the i.M.A.G.E., a single-use made-to-measure instrument system; and E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery. The company exports its products through a network of distributors and agents in approximately 30 countries. It serves patients, surgeons, and healthcare facilities. Amplitude Surgical SA was founded in 1997 and is headquartered in Valence, France. As of July 29, 2025, Amplitude Surgical SA operates as a subsidiary of Zydus Lifesciences Limited.
Visit company website
5 years, 4 months ago
Amplitude Surgical SA is currently in a long term uptrend where the price is trading 1.8% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.2.
Amplitude Surgical SA's total revenue sank by 0.0% to $22M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $-4M since the same quarter in the previous year.
Finally, its free cash flow fell by 148.1% to $-2M since the same quarter in the previous year.
Based on the above factors, Amplitude Surgical SA gets an overall score of 2/5.